Medicare Enrolled
Dr. Sophie Shirin
Dermatology · Encino, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shirin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shirin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shirin
Dr. Sophie Shirin is a dermatology specialist in Encino, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Shirin performed 9,610 Medicare services across 5,077 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shirin received a total of $9,251 from 40 pharmaceutical and/or device companies across 346 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shirin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 9% volume in CA
$9,251 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,610
Medicare services
Top 9% in CA for dermatology
5,077
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~534 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
3,117 | $6 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,136 | $79 | $120 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
961 | $102 | $147 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
950 | $50 | $120 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
532 | $97 | $250 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
463 | $44 | $55 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
455 | $81 | $120 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
279 | $51 | $80 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
185 | $114 | $146 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
90 | $571 | $799 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
90 | $1 | $10 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
77 | $43 | $72 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
52 | $228 | $541 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
45 | $47 | $71 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
33 | $158 | $206 |
| Destruction of skin growth, 15 or more growths | 31 | $123 | $165 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $105 | $131 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
24 | $125 | $175 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
23 | $148 | $184 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 23 | $361 | $450 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
15 | $68 | $170 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,251
Total received (2018-2024)
Avg $1,322/year across 7 years
Top 18% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
346
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,251 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,030
2023
$2,772
2022
$1,966
2021
$500
2020
$359
2019
$645
2018
$977
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$346
ABBVIE INC.
$314
Regeneron Healthcare Solutions, Inc.
$255
Janssen Biotech, Inc.
$200
PFIZER INC.
$155
UCB, Inc.
$106
REVANCE THERAPEUTICS, INC.
$96
E.R. Squibb & Sons, L.L.C.
$87
Amgen Inc.
$78
Lilly USA, LLC
$72
Dermavant Sciences, Inc.
$70
SUN PHARMACEUTICAL INDUSTRIES INC.
$69
Novartis Pharmaceuticals Corporation
$54
Incyte Corporation
$51
Arcutis Biotherapeutics, Inc.
$43
Ortho Dermatologics, a division of Bausch Health US, LLC
$17
MAYNE PHARMA COMMERCIAL LLC
$17
Top 3 companies account for 45.1% of 2024 payments
All-time payments by company (2018-2024) ›
Merz North America, Inc.
$2,539
Regeneron Healthcare Solutions, Inc.
$973
GENZYME CORPORATION
$851
Amgen Inc.
$516
PFIZER INC.
$489
ABBVIE INC.
$430
Janssen Biotech, Inc.
$420
AbbVie Inc.
$290
E.R. Squibb & Sons, L.L.C.
$258
LEO Pharma Inc.
$258
Novartis Pharmaceuticals Corporation
$234
Celgene Corporation
$216
Lilly USA, LLC
$170
Incyte Corporation
$166
Dermavant Sciences, Inc.
$149
Galderma Laboratories, L.P.
$128
Allergan, Inc.
$122
UCB, Inc.
$106
REVANCE THERAPEUTICS, INC.
$96
SUN PHARMACEUTICAL INDUSTRIES INC.
$89
Arcutis Biotherapeutics, Inc.
$81
Mylan Pharmaceuticals Inc.
$76
MAYNE PHARMA INC.
$73
MAYNE PHARMA COMMERCIAL LLC
$67
Sun Pharmaceutical Industries Inc.
$64
Ortho Dermatologics, a division of Bausch Health US, LLC
$56
AbbVie, Inc.
$52
Genentech USA, Inc.
$33
Smith+Nephew, Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Biofrontera Inc.
$27
Encore Dermatology Inc.
$25
Sandoz Inc.
$22
Organogenesis Inc.
$21
MERZ NORTH AMERICA, INC.
$19
Merck Sharp & Dohme Corporation
$18
Mayne Pharma Inc.
$18
EPI Health, LLC
$15
DERMIRA, INC.
$14
Allergan Inc.
$11
Top 3 companies account for 47.2% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · Ameluz · BOTOX · BOTOX COSMETIC · Bimzelx · COLLAGENASE SANTYL · COSENTYX · Cabtreo · DAXXIFY · DORYX · DUOBRII · DUPIXENT · Doxepin Hydrochloride · EFUDEX · ENSTILAR · EPIDUO FORTE · EUCRISA · Erivedge · FINACEA · Humira · ILUMYA · Ilumya · Impoyz · LIBTAYO · OLUMIANT · OPZELURA · Odomzo · Olux · Otezla · PICATO · Puraply · QBREXZA · RINVOQ · SIVEXTRO · SKYRIZI · SPEVIGO · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRILUMA · VTAMA · Winlevi · XEOMIN · Xeomin · Zonalon · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
430
Per 100K population
4.4
County median income
$87,760
Nearest hospital
ENCINO HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shirin is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shirin experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Shirin performed 3,117 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shirin receive payments from pharmaceutical companies?
Yes. Dr. Shirin received a total of $9,251 from 40 companies across 346 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shirin's costs compare to other dermatologists in Encino?
Dr. Shirin's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shirin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Encino
Browse dermatologists in Encino ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
Merz North America, Inc. Payments to Doctors
See all physicians who received payments from Merz North America, Inc.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology